08/21/2024
5:19 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:21 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:22 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:24 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:26 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:28 PM | Cytek Biosciences (Issuer)
Holder Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:15 PM | Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
4:16 PM | Cytek Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
3:16 PM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
5:51 PM | Cytek Biosciences (Issuer)
HARDISON DON M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:53 PM | Cytek Biosciences (Issuer)
Imper Vera (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:59 PM | Cytek Biosciences (Issuer)
NEFF DEBORAH J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:03 PM | Ball Jack (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:05 PM | Cytek Biosciences (Issuer)
Holder Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/07/2024
6:09 PM | Cytek Biosciences (Issuer)
Holder Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:48 PM | Cytek Biosciences (Filer)
| Form SD
Specialized Disclosure Report | |
05/22/2024
5:36 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:41 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:28 PM | Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:31 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:32 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:34 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:19 PM | Cytek Biosciences (Issuer)
McCombe William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
3:26 PM | Cytek Biosciences (Filer)
| Form ARS | |
04/23/2024
5:07 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:17 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:21 PM | Cytek Biosciences (Subject)
Yan Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
5:19 PM | Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:27 PM | Cytek Biosciences (Issuer)
McCombe William D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/19/2024
5:25 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:35 PM | Cytek Biosciences (Subject)
Yan Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
5:53 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:55 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:44 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:48 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:50 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:39 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:42 PM | Cytek Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
5:44 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:46 PM | Busque Philippe (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:47 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade |
03/08/2024
5:49 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:51 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:52 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:05 PM | Cytek Biosciences (Filer)
| Form NT 10-K | |
03/01/2024
5:06 AM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
5:06 AM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:07 PM | Cytek Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
02/22/2024
4:37 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:46 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:49 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:50 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:32 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:34 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:12 PM | BROWN CAPITAL MANAGEMENT LLC (Filed by)
Cytek Biosciences (Subject)
| Form SC 13G | |
01/23/2024
3:13 PM | BlackRock Inc. (Filed by)
Cytek Biosciences (Subject)
| Form SC 13G/A | |
01/09/2024
5:05 AM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:36 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:35 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:28 PM | Cytek Biosciences (Subject)
Yan Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023
6:00 AM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
7:48 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
7:53 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:56 PM | Cytek Biosciences (Issuer)
Williams Paul Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:59 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:46 PM | Barnett Valerie (Reporting)
Cytek Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:48 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:52 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:54 PM | Cytek Biosciences (Issuer)
Poirson Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:39 PM | Cytek Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
5:06 AM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
5:03 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:45 PM | Cytek Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
5:29 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:36 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2023
3:02 PM | Cytek Biosciences (Subject)
Yan Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023
6:25 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
7:32 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
5:42 PM | Cytek Biosciences (Issuer)
Jeanmonod Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
5:27 PM | Cytek Biosciences (Issuer)
Yan Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
4:25 PM | Cytek Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/08/2023
6:12 PM | Cytek Biosciences (Issuer)
Jiang Wenbin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:15 PM | Cytek Biosciences (Subject)
Jiang Wenbin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free CTKB Stock Alerts